Table 2 Factors associated with unvaccinated status for COVID-19
Variables | Unvaccinated (n = 144) | Vaccinated (n = 85) | P-value | Univariate analysis | Multivariate analyses | ||
|---|---|---|---|---|---|---|---|
Odds ratio (95% CI) | P-value | Adjusted odds ratio (95% CI) | P-value | ||||
Male, (%) | 110 (76.4) | 62 (72.9) | 0.67 | 1.20 (0.65–2.22) | 0.56 | ||
Age (years), mean (SD) | 57.4 (11.8) | 56.3 (12.8) | 0.52 | 1.01 (0.99–1.03) | 0.52 | ||
Systemic hypertension, (%) | 27 (18.8) | 13 (15.3) | 0.63 | 1.28 (0.62–2.64) | 0.51 | ||
Type II Diabetes, (%) | 26 (18.1) | 8 (9.4) | 0.11 | 2.12 (0.91–4.93) | 0.08 | ||
Etiology of cirrhosis, (%) | |||||||
Viral | 96 (66.7) | 53 (62.4) | 0.30 | 1.44 (7.08–0.29) | 0.83 | ||
Alcohol | 13 (9.0) | 4 (4.7) | |||||
AIH | 9 (6.2) | 4 (4.7) | |||||
Cholestasis | 7 (4.9) | 3 (3.5) | |||||
Others | 10 (6.9) | 12 (14.1) | |||||
Multi | 9 (6.2) | 9 (10.6) | |||||
Experience of acute deterioration, (%) | |||||||
Ascites (Grade II–III) | 119 (82.6) | 70 (82.4) | 1.00 | 1.02 (0.50–2.06) | 0.96 | ||
GEVB | 14 (9.7) | 4 (4.7) | 0.27 | 2.18 (0.69–6.86) | 0.18 | ||
HEa | 16 (11.1) | 2 (2.4) | 0.03 | 5.19 (1.16–23.15) | 0.03 | 5.61 (1.24–25.4) | 0.025 |
Bacterial/fungal infection | 31 (21.5) | 15 (17.6) | 0.60 | 1.28 (0.65–2.54) | 0.48 | ||
AKI | 13 (9.0) | 6 (7.1) | 0.78 | 1.31 (0.48–3.58) | 0.60 | ||
ACLFa | 23 (16.0) | 5 (5.9) | 0.04 | 3.04 (1.11–8.33) | 0.03 | 3.13 (1.12–8.69) | 0.029 |
LT recipient (%)a | 29 (20.1) | 8 (9.4) | 0.05 | 2.43 (1.05–5.59) | 0.04 | 2.47 (1.06–5.76) | 0.037 |
Current living area (%) | |||||||
Rural | 54 (37.8) | 41 (48.2) | 0.16 | 0.65 (0.38–1.12) | 0.12 | ||
Shanghaib | 71 (49.3) | 24 (28.2) | < 0.01 | 2.47 (1.39–4.39) | < 0.01 | 2.55 (1.41–4.59) | 0.002 |